158 related articles for article (PubMed ID: 16553028)
21. Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institution.
Segerhammar I; Larsson C; Nilsson IL; Bäckdahl M; Höög A; Wallin G; Foukakis T; Zedenius J
J Surg Oncol; 2012 Dec; 106(8):981-6. PubMed ID: 22674491
[TBL] [Abstract][Full Text] [Related]
22. Time trend in tumour size and characteristics of anaplastic thyroid carcinoma.
Han JM; Bae Kim W; Kim TY; Ryu JS; Gong G; Hong SJ; Kim JH; Oh YL; Jang HW; Kim SW; Chung JH; Shong YK
Clin Endocrinol (Oxf); 2012 Sep; 77(3):459-64. PubMed ID: 22458627
[TBL] [Abstract][Full Text] [Related]
23. A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients.
Busnardo B; Daniele O; Pelizzo MR; Mazzarotto R; Nacamulli D; Devido D; Mian C; Girelli ME
J Endocrinol Invest; 2000 Dec; 23(11):755-61. PubMed ID: 11194710
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological Spectrum of Anaplastic Carcinoma of Thyroid - 5 Year Experience from a Tertiary Cancer Centre.
Manjusha P; Kandathil JP; Nayanar SK; Jones J; Sajith B
Gulf J Oncolog; 2018 Sep; 1(28):17-22. PubMed ID: 30344129
[TBL] [Abstract][Full Text] [Related]
25. Prospective application of our novel prognostic index in the treatment of anaplastic thyroid carcinoma.
Orita Y; Sugitani I; Amemiya T; Fujimoto Y
Surgery; 2011 Dec; 150(6):1212-9. PubMed ID: 22136842
[TBL] [Abstract][Full Text] [Related]
26. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
[TBL] [Abstract][Full Text] [Related]
27. Anaplastic thyroid carcinoma: a 25-year single-institution experience.
Mohebati A; Dilorenzo M; Palmer F; Patel SG; Pfister D; Lee N; Tuttle RM; Shaha AR; Shah JP; Ganly I
Ann Surg Oncol; 2014 May; 21(5):1665-70. PubMed ID: 24554064
[TBL] [Abstract][Full Text] [Related]
28. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.
Kebebew E; Greenspan FS; Clark OH; Woeber KA; McMillan A
Cancer; 2005 Apr; 103(7):1330-5. PubMed ID: 15739211
[TBL] [Abstract][Full Text] [Related]
29. [Anaplastic carcinoma of the thyroid at the Instituto Nacional de la Nutrición Salvador Zubirán].
Sierra M; Gamboa-Domínguez A; Herrera MF; Barredo-Prieto B; Alvarado de la Barrera C; Llorente L; Pérez-Enriquez B; Rivera R; González O; Rull JA
Rev Invest Clin; 1997; 49(2):97-103. PubMed ID: 9380971
[TBL] [Abstract][Full Text] [Related]
30. Anaplastic thyroid carcinoma: a case of a young women that reports a survival exceeding 6 years.
Batori M; Chatelou E; Straniero A; Ruggieri M
Eur Rev Med Pharmacol Sci; 2007; 11(1):69-71. PubMed ID: 17405351
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of β-human chorionic gonadotropin and PAX8 expression in anaplastic thyroid carcinoma.
Becker N; Chernock RD; Nussenbaum B; Lewis JS
Thyroid; 2014 Feb; 24(2):319-26. PubMed ID: 23806007
[TBL] [Abstract][Full Text] [Related]
32. Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Heikkilä A; Heiskanen I; Arola J; Haglund C
Oncology; 2010; 79(5-6):400-8. PubMed ID: 21455012
[TBL] [Abstract][Full Text] [Related]
33. Survival and Prognostic Factors of Anaplastic Thyroid Carcinoma.
Paunovic IR; Sipetic SB; Zoric GV; Diklic AD; Savic DV; Marinkovic J; Zivaljevic VR
Acta Chir Belg; 2015 Jan; 115(1):62-7. PubMed ID: 27384898
[TBL] [Abstract][Full Text] [Related]
34. [Differential diagnosis and strategy for the treatment of anaplastic thyroid carcinoma].
Suzuki S
Nihon Rinsho; 2007 Nov; 65(11):2079-86. PubMed ID: 18018574
[TBL] [Abstract][Full Text] [Related]
35. Optimal combination of treatment modality to increase survival in patients with anaplastic thyroid carcinoma: A STROBE compliant retrospective study.
Lee JH; Ahn HK; Seok JY; Lee KC; Chun YS; Chung YS; Lee YD
Medicine (Baltimore); 2018 Jun; 97(25):e11037. PubMed ID: 29923991
[TBL] [Abstract][Full Text] [Related]
36. Anaplastic thyroid carcinoma. Practical aspects of multimodal therapy and data emerging from a 40-year experience at a single Italian institution.
Baroli A; Pedrazzini L; Lomuscio G; Marzoli L
Minerva Endocrinol; 2010 Mar; 35(1):9-16. PubMed ID: 20386523
[TBL] [Abstract][Full Text] [Related]
37. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
[TBL] [Abstract][Full Text] [Related]
38. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches.
Are C; Shaha AR
Ann Surg Oncol; 2006 Apr; 13(4):453-64. PubMed ID: 16474910
[TBL] [Abstract][Full Text] [Related]
39. [Anaplastic thyroid carcinoma: diagnosis, treatment and prognosis].
Demidchik IuE; Fridman MV; Pisarenko AM
Vopr Onkol; 2007; 53(1):37-45. PubMed ID: 17649732
[TBL] [Abstract][Full Text] [Related]
40. [Anaplastic carcinoma of the thyroid: diagnosis and treatment].
Giuffrida D; Lavenia G; Aiello RA; Di Blasi C; Gambera G; Pappalardo A; Petralia G; Ursino M; Failla G
Clin Ter; 2001; 152(4):255-61. PubMed ID: 11725619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
